Page last updated: 2024-10-25

deferoxamine and Pancreatic Diseases

deferoxamine has been researched along with Pancreatic Diseases in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erttmann, R1
Hausdorf, G1
Landbeck, G1
Ley, TJ1
Griffith, P1
Nienhuis, AW1

Reviews

1 review available for deferoxamine and Pancreatic Diseases

ArticleYear
Transfusion haemosiderosis and chelation therapy.
    Clinics in haematology, 1982, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Ascorbic Acid; Blood Transfusion; Cardiomyopathies; Deferoxamine; Dose-Response R

1982

Other Studies

1 other study available for deferoxamine and Pancreatic Diseases

ArticleYear
Pancreatic sonography in thalassemia major.
    Klinische Padiatrie, 1983, Volume: 195, Issue:2

    Topics: Adolescent; Adult; Blood Transfusion; Child; Deferoxamine; Hemosiderosis; Humans; Pancreatic Disease

1983